Hepatic (liver) and renal (kidney) cysts are fluid-filled sacs that develop in or on these organs, and in the vast majority of cases they are harmless, cause no symptoms, and require no treatment. Simple cysts are by far the most common type, often discovered incidentally on imaging done for an unrelated reason. The picture gets more complicated when cysts grow large enough to press on surrounding structures, when they arise as part of a genetic polycystic disease, or when an infection is involved. Understanding what kind of cyst you’re dealing with shapes every decision that follows, from whether to watch and wait to whether surgery makes sense.
Why Simple Cysts Form
Simple cysts of the liver are defined by thin walls, at most one or two thin internal dividers, and uniform fluid content. They include congenital epithelial cysts, biliary hamartomas, and peribiliary cysts, among other subtypes.1Europe PMC / Colégio Brasileiro de Radiologia e Diagnóstico por Imagem. Hepatic cysts: a survival guide Most are thought to originate from abnormal bile duct development before birth, leaving behind small pockets of tissue that slowly fill with fluid over a lifetime. They are remarkably common; imaging studies consistently find them in a sizable share of adults, and the prevalence climbs with age.
Simple kidney cysts have a different developmental story. Research dating back decades traced their origin to tiny outpouchings on the distal tubules and collecting ducts of the kidney. These outpouchings increase in number as people age, likely because the tubular walls weaken over time. The progression runs from microscopic diverticula to small cysts to the kind of cyst that eventually shows up on a scan.2PubMed. Is the diverticulum of the distal and collecting tubules a preliminary stage of the simple cyst in the adult? A detached segment of tubule creates a sealed pocket, and fluid accumulates.3The Open Urology & Nephrology Journal. A Complicated “Simple” Renal Cyst Because this process is essentially wear-and-tear, simple renal cysts are unusual in young adults and almost expected in people over 50.
Genetic Polycystic Diseases
When dozens or hundreds of cysts develop in the kidneys, liver, or both, a hereditary condition is usually responsible. These are fundamentally different from the solitary simple cysts described above, both in their cause and in their potential to damage organ function.
Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease in adults. It is primarily driven by mutations in two genes, PKD1 and PKD2, though researchers have identified additional causative genes in recent years, revealing more genetic complexity than was once appreciated.4npj Genomic Medicine. PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan Cysts in ADPKD enlarge progressively and can eventually crowd out functional kidney tissue, leading to kidney failure in a substantial fraction of patients by middle age. The liver is frequently involved too; many people with ADPKD also develop polycystic liver disease, though the liver cysts in this context tend to cause fewer functional problems than the kidney cysts.
Polycystic Liver Disease Without Kidney Involvement
A separate condition, autosomal dominant polycystic liver disease (PCLD), is characterized by the progressive growth of twenty or more liver cysts in the absence of significant kidney disease. Two genes, PRKCSH and SEC63, are known to cause familial PCLD.5PubMed. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease Even so, mutations in these genes are found in only about a quarter of patients with PCLD, suggesting that other genetic causes remain undiscovered.6PubMed. Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease The proteins made by these genes work inside cells in ways that affect how other proteins are processed and folded, but how exactly that leads to cyst formation is still not fully understood. Patients with more than twenty cysts are more likely to carry a detectable mutation, though people with as few as eight cysts can be carriers too.
Autosomal Recessive Polycystic Kidney Disease in Children
The childhood counterpart, autosomal recessive polycystic kidney disease (ARPKD), looks quite different from its dominant relative. The kidneys become enlarged and sponge-like because the collecting ducts dilate without obstruction, and the liver develops congenital hepatic fibrosis rather than discrete fluid-filled cysts.7PubMed Central. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF) The disease ranges widely in severity: some infants present with life-threatening kidney failure at birth, while others reach adolescence before liver-related complications like portal hypertension become the main problem. Management decisions need to weigh both organs, and plans for eventual kidney transplantation can influence how aggressively liver complications are treated.8PubMed Central. Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease
Infectious Cysts
Not all cysts arise from developmental quirks or inherited genes. In regions where sheep are raised and dogs are used to herd livestock, cystic hydatid disease caused by the tapeworm Echinococcus granulosus is a well-recognized cause of liver and sometimes lung cysts. Humans become infected by accidentally ingesting tapeworm eggs shed by dogs. The larvae migrate to the liver, where they form slow-growing cysts that can reach considerable size before producing symptoms like abdominal fullness or pain.9Oxford Textbook of Medicine. Cystic hydatid disease (Echinococcus granulosus) Hydatid cysts have a distinctive layered structure on imaging that helps distinguish them from simple cysts, though the diagnosis sometimes requires blood tests or examination of the cyst fluid. Treatment usually involves a combination of anti-parasitic medication and surgery or percutaneous drainage, depending on the size and location of the cyst.
When Cysts Cause Symptoms
The vast majority of simple hepatic and renal cysts are completely silent. Symptoms emerge only when a cyst grows large enough to physically compress neighboring structures, or when a complication like infection or bleeding develops inside the cyst.
In the liver, congenital cysts rarely reach a size that matters, but when they do, the consequences can be dramatic. Case reports describe giant liver cysts causing intestinal obstruction, respiratory distress from upward pressure on the diaphragm, and recurrent vomiting.10PubMed Central. Intestinal obstruction due to giant liver cyst: A case report Because cysts within the liver sit close to both the vascular and biliary systems, compression can also lead to obstructive jaundice, portal hypertension, or even Budd-Chiari syndrome if the hepatic veins are squeezed.11Radiology Case Reports. Giant hepatic cyst as a cause of gastric outlet obstruction These scenarios are rare with simple cysts but become a real concern in polycystic liver disease, where the cumulative mass of dozens of cysts can distort the entire organ.
Large renal cysts most often present with dull flank pain or a sensation of fullness. There is also evidence that some large kidney cysts can raise blood pressure by compressing nearby kidney tissue and triggering the body’s blood-pressure-raising hormone cascade. In reported cases, blood pressure dropped once the cyst was drained, confirming the cyst as the cause.12PubMed. Simple renal cyst and hypertension: cause or coincidence? This is uncommon, but worth considering in someone with a large cyst and hard-to-control blood pressure.
Pain is a major issue in polycystic kidney disease specifically. It is one of the most common and most disabling symptoms patients report, yet it is frequently underrecognized and undertreated in routine care.13PubMed Central. The Importance of Recognizing Pain in Patients With Autosomal Dominant Polycystic Kidney Disease The pain can come from the cysts themselves, from kidney stones (which are more common in ADPKD), from cyst infections, or from the sheer weight and stretch of massively enlarged kidneys.
How Cysts Are Classified on Imaging
When a kidney cyst is found on a CT scan or MRI, radiologists use the Bosniak classification to sort it into one of several categories based on its appearance. This system has been used for over 30 years to estimate how likely a cystic kidney mass is to be cancerous.14PubMed Central. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment A category I cyst is a classic simple cyst with virtually zero cancer risk and needs no follow-up. Higher categories introduce features like internal dividers, calcification, thickening of the wall, or areas that enhance with contrast dye, each bumping up the estimated risk and potentially calling for surveillance or surgery. Systematic reviews confirm that the Bosniak system is accurate for stratifying this risk.15PubMed Central. Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography – a systematic review and meta-analysis
For liver cysts, no single classification system is as universally adopted, but radiologists look for several red flags that distinguish a potentially worrisome cystic mass from a benign simple cyst. The presence of thick internal dividers arising directly from the cyst wall, rather than from an external indentation, is strongly associated with a biliary cystadenoma, a type of cystic tumor.16PubMed. Differentiating biliary cystadenomas from benign hepatic cysts: Preliminary analysis of new predictive imaging features Other suspicious features include nodularity within the cyst, dilation of nearby bile ducts (which had the highest specificity in one study), internal debris or hemorrhage, and having fewer than three other simple cysts elsewhere in the liver.17PubMed. Differentiation between biliary cystic neoplasms and simple cysts of the liver: accuracy of CT18PubMed. CT and MRI features differentiating mucinous cystic neoplasms of the liver from pathologically simple cysts That last point is counterintuitive: if you have many cysts scattered throughout the liver, each individual cyst is more likely to be a simple cyst; a lone complex-looking cyst in an otherwise normal liver deserves closer scrutiny.
Percutaneous Aspiration and Sclerotherapy
For a simple cyst that is causing pain or other symptoms, the least invasive first step is usually draining it with a needle inserted through the skin under ultrasound or CT guidance. Drainage alone, however, has a high recurrence rate because the cyst lining remains intact and continues to secrete fluid. That is why aspiration is typically paired with sclerotherapy: after the fluid is drained, an agent like ethanol is injected into the empty cyst cavity to destroy the lining cells and prevent refilling.
In renal cysts, alcohol sclerotherapy achieves an average volume reduction of over 90%, with pain improving in essentially all patients regardless of whether the cyst completely disappears or just shrinks substantially.19PubMed Central. Alcohol sclerotherapy in the treatment of symptomatic simple renal cysts A study comparing different ethanol retention times found that the overall volume reduction reached about 98%, with many cysts disappearing entirely and others shrinking to residual diameters well under 3 cm.20PubMed. Single-session alcohol-retention sclerotherapy for simple renal cysts: comparison of 2- and 4-hr retention techniques
The results for hepatic cysts are similarly encouraging. In one series, 97% of sclerotherapy procedures were technically successful, the average cyst diameter shrank from 9 cm to 3 cm, and most patients became either symptom-free or experienced significantly milder pain. Recurrence was essentially nonexistent in treated cysts, though patients with polycystic liver disease sometimes had new symptoms from the growth of untreated cysts elsewhere.21Journal of Vascular and Interventional Radiology. Percutaneous Aspiration and Ethanol Sclerotherapy for Symptomatic Hepatic Cysts This highlights an important limitation: sclerotherapy works well for individual symptomatic cysts, but it cannot address the underlying disease process in polycystic conditions where new cysts keep forming.
Surgical Options
When sclerotherapy fails, when the cyst recurs, or when the anatomy makes percutaneous access difficult, surgery becomes the next option. The standard approach for both liver and kidney cysts is laparoscopic deroofing (also called decortication), in which the surgeon removes the portion of the cyst wall that protrudes from the organ surface, allowing the cavity to drain freely into the abdominal space where the fluid is reabsorbed.
For liver cysts, this involves aspirating the cyst fluid during surgery and then cutting away the exposed cyst wall near the transition zone where it meets normal liver tissue.22PubMed Central. Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis A review of the literature found that while the basic technique is straightforward, surgeons sometimes add supplementary steps such as packing the residual cavity with a flap of omentum (the fatty apron in the abdomen) or using energy devices and linear staplers to manage the cyst wall edges. Newer approaches have incorporated fluorescence imaging with indocyanine green dye to better visualize the cyst margins, though this is still used in a minority of cases.23European Surgery. Laparoscopic deroofing of simple liver cysts: do ancillary techniques, surgical devices, and indocyanine green improve outcomes?
For kidney cysts, laparoscopic decortication is considered the standard of care, especially after a failed percutaneous attempt.24PubMed Central. The laparoscopic management of symptomatic renal cysts: A single-centre experience Long-term follow-up data are reassuring: in one study, all patients with simple cysts who underwent laparoscopic decortication for pain were pain-free at their last follow-up visit.25PubMed. Role and long-term results of laparoscopic decortication in solitary cystic and autosomal dominant polycystic kidney disease Single-incision laparoscopic surgery is also gaining traction as an alternative that offers a better cosmetic result, which is particularly appealing when both kidneys need treatment.24PubMed Central. The laparoscopic management of symptomatic renal cysts: A single-centre experience
Drug Treatments for Polycystic Disease
Simple cysts do not call for medication. But polycystic kidney and liver diseases, where cyst growth is driven by specific molecular pathways, have become targets for pharmacological therapy.
The biggest advance for ADPKD has been tolvaptan, a drug that blocks a hormone receptor (vasopressin V2) on kidney cells. By doing so, it dials down two processes that fuel cyst growth: cell proliferation and fluid secretion into cyst cavities.26Childhood Kidney Diseases. Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease? Its approval was based on landmark trials showing that it slows the decline in kidney function. In a trial of patients with later-stage disease, those on tolvaptan lost kidney function at a rate of about 2.3 mL per minute per year, compared to roughly 3.6 mL per minute per year on placebo, a meaningful slowing of disease progression.27PubMed. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease Tolvaptan does come with significant side effects, including intense thirst and large volumes of dilute urine (because of how it works on the kidney), as well as a risk of liver injury that requires regular blood monitoring.28PubMed Central. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
For polycystic liver disease specifically, somatostatin analogues like octreotide and pasireotide have been studied. Unlike vasopressin receptors, somatostatin receptors are expressed on the bile duct cells and liver cells that line hepatic cysts, giving these drugs a direct route of action in the liver.29Scientific Reports. The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials In one trial, octreotide produced a modest reduction in liver volume, driven mainly by a shrinkage of the liver tissue (parenchyma) itself.30PubMed Central. Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide The reductions are not dramatic, but for patients whose quality of life is impaired by massive liver enlargement, any measurable shrinkage can translate into meaningful symptom relief.
Dealing with Infected Cysts
Cyst infection is one of the most troublesome complications of polycystic disease, and it can be surprisingly difficult to diagnose and treat. Standard imaging methods like ultrasound, CT, and MRI often struggle to pinpoint which cyst among dozens is infected. PET scanning, which detects areas of heightened metabolic activity, has proven considerably better at identifying the culprit cyst.31PubMed Central. Cyst infections in patients with autosomal dominant polycystic kidney disease
Treating infected cysts is complicated by the fact that most antibiotics penetrate cyst fluid poorly. A pharmacokinetic study that measured drug levels inside liver cysts found highly variable penetration across different antibiotics. Ciprofloxacin and trimethoprim penetrated best, though even ciprofloxacin only reached therapeutic levels in just over half of samples at a single low dose. The components of the common combination drug co-trimoxazole had a striking mismatch: trimethoprim got in at roughly 12%, but sulfamethoxazole barely entered at all, at under 1%. Since trimethoprim alone is not effective against most of the bacteria that infect cysts, this mismatch helps explain why co-trimoxazole often fails in practice. Ciprofloxacin remains the preferred first-line antibiotic when the infecting organism is susceptible.32Journal of Antimicrobial Chemotherapy. Liver cyst penetration of antibiotics at the target site of infection: a randomized pharmacokinetic trial When antibiotics alone cannot clear the infection, draining the infected cyst becomes necessary, and this is typically done with a percutaneous catheter.31PubMed Central. Cyst infections in patients with autosomal dominant polycystic kidney disease
Caffeine and Polycystic Kidney Disease
One of the most persistent pieces of advice circulating in patient communities is that people with ADPKD should avoid caffeine. The concern stems from laboratory studies suggesting that caffeine can promote cyst growth in cell models. However, the clinical evidence has not supported a meaningful link. A study that correlated caffeine intake with kidney volume and kidney function in ADPKD patients found no association between how much caffeine people consumed and how large their kidneys were or how well they functioned, even after adjusting for age.33PubMed Central. Caffeine intake by patients with autosomal dominant polycystic kidney disease A separate retrospective analysis using a large, well-characterized cohort reached the same conclusion: caffeine did not have a significant detrimental effect on disease progression.34PubMed Central. Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort Moderate caffeine intake appears to be safe for most ADPKD patients, though very high consumption has not been as thoroughly studied, so moderation remains a reasonable default.
Rare Look-Alikes on Imaging
Occasionally, what appears to be a cluster of small liver cysts turns out to be something else entirely. Von Meyenburg complexes, also known as biliary hamartomas, are tiny malformations of the bile ducts that show up on MRI as multiple small bright spots scattered through the liver. They do not communicate with the main bile duct system and are usually harmless, but they can mimic the appearance of metastatic disease or early polycystic liver disease on imaging, causing unnecessary alarm.35PubMed Central. The clinical presentation of Von Meyenburg complexes MRI with specialized bile-duct imaging sequences can usually make the distinction. Recognizing these lesions saves patients from invasive workups that would be unwarranted.